2. New technologies (materials, substances, technique) are a
basis of contemporary economy and an ideal target for
investment.
Science produces plenty of new technologies, which can be
converted into business product, and create revenue.
However investors have no
access to information about
99% of new technologies.
They know about these
technologies only when
somebody else has used
them to bring new product to
the market.
Problem
3. Scientific networks have no contact or
crossing with investors’ networks.
Scientific Output comes in form of verbose
papers, inaccessible and incomprehensible
for people outside of academy.
Investors’ Input comes in form of simple and
short presentations and business plans,
which scientists are not used to make.
Reasons
4. SciTree – a web platform for collaboration
between scientists and investors
• Changing scientific Output :short statement
about new technology (25 words)+ link to a
paper
• Investors can choose a technology they
want to turn into a product
• Investors can set a task for a research group
(to develop a new material, f.e.)
• Constant monitoring of new technologies
Solution
5. Over 5 million scientists are developing new technologies
(biology, medicine, materials, etc).
Scientists get financing by writing articles for peer-review
journals and project proposals for research funds
(government organizations), which takes up to 50% of their
working time. This is ineffective usage of their time and
brainpower.
Companies spend up to 43% of revenue on R&D (Allergan –
43.4%, Eriksson – 24.9%). New technologies are important for
progress and successful competition. However these
investments do not guarantee good results, as discoveries in
science happen irregularly. Thus, it is highly expensive and not
that effective to have an R&D department in a company.
With SciTree entire science can be used as your own R&D
department. Outsource your R&D anywhere.
Market
6. Social network for scientists, 1.7
million users. Deficiencies:
scientists only, output in a form of
big articles.
Social network for scientists,
1.8 million users. Deficiencies:
scientists only, output in a
form of big articles.
A consulting firm, helping to find
objects of investment.
Deficiencies: high price, lack of
transparency, lack of direct
contacts with scientists.
Competitors
7. Elena Kalmykova, CEO
PhD in Philosophy (Uppsala University, Sweden). Graduated
from Oriental and Philosophy Faculties at Saint-Petersburg State
University.
Courses attended: Technology Entrepreneurship (Stanford
University), Researchers and Leadership (Swedish Institute).
Published over 20 papers on the topics such as structure of
scientific knowledge and communication in science.
Work experience in web-projects: Electric Jungle (Sun
Microsystems), SMM, web design, member of Wallenberg
Calendar team.
John Noel M. Viaña
BS in Molecular Biology and Biotechnology (University of the
Philippines - Diliman).
Has worked at the Laboratory of Molecular and Cell Biology at the
National Institute of Molecular Biology and Biotechnology, UP
Diliman
Member of international honor societies (Phi Kappa Phi and Phi
Sigma Biological Sciences Honor Society). Courses attended:
Technological Entrepreneurship at Stanford’s Venture Lab.
Team
8. Investors:pay for
Advertising: targeted ads subscription (golden and
(lab equipment, laptops etc) silver membership), exclusive
access to information
Investors: pay for review of
dynamics of field
Scientists: pay to promote
development, analytics,
your news or team
consulting and selection of
teams for investment
Investors and visitors:
Universities: pay for
donate for a specific research,
advertising academic jobs
we keep 5% of donation
Marketing